New data published this month by Future Market Insights reveals the global shipments for medical wearable devices in the first half of 2016. According to the report shipments of such devices will surpass 106 million in 2016. Revenue for the devices are expected to cross $US 23,980 million, which is a 4.8% growth year over year. Biotricity, Siemens, Fitbit, Medtronic, Koninklijke Philips.
The report explains the increase in popularity of medical weatrable devices by pointing out that the new technology, for the first time, is allowing patients with diseases that require round-the-clock monitoring, to be more flexible. Devices are now able to deliver crucial data to physicians from afar, in real time.
The report indicates that the main obstacle for such devices are the high cost. This too is temporary, as competition is expected to grow in this field, which drive prices down and making the devices more affordable.
As a result of high growth potential in an expanding segment of an already popular sector, start-ups and SMEs (small and medium size enterprises) have appeared. Companies like Biotricity have been active in development and innovation of medically relevant biometric remote monitoring solutions.
Biotricity’s first medical solution, the Bioflux will combine a proprietary mobile ECG monitoring device and an ECG viewer software package. The combination will enable physicians to remotely monitor and diagnose patients with cardiovascular disease and coronary heart disease by detecting arrhythmias, using an accredited 24-hour, 7 day per week, ECG monitoring facility. Earlier in June, Biotricity has filed for a 510(k) with the U.S. Food and Drug Administration (FDA), and expects to receive a response submission by early fall.
An upcoming catalyst for the company was released on July 5th, Biotricity announced that it “will be demonstrating its revolutionary Internet of Things (IoT) -connected medical device at Shape, an AT&T Tech Expo being held on July 15-16, 2016 at AT&T Park in San Francisco, CA.“
The leading player in the wearable devices sector remains Fitbit, yet their devices are more fitness trackers than medical devices. As competition intensified however, Fitbit was forced to rethink its business and what their next step will be. As was expected, in April the company announced that it will venture into medical devices. This is an important catalyst for Fitbit, as the FDA will test the company’s technology and comment on it.
Other major players in this sector include Medtronic, Siemens, andKoninklijke Philips all of which have medical wearable devices of some kind in their product portfolios already, and plan to expand further their presence in this sector. Medtronic plc in particular has released impressive technology. The company’s devices manufactured with sophisticated sensors, which monitor metabolic changes and generate results in seconds.
The popularity of such devices is expected to gain traction globally, but for now North America is still the largest market, followed by Western Europe and then by the Asian Pacific region.
Find out more by visiting www.FinancialBuzz.com.
